DISEASE RISK ASSESSEMENT PROFILE

File: 102596_sep96_decls1_0002.txt
Page: 0002
Total Pages: 16

Subject: DISEASE RISK ASSESSEMENT PROFILE                                

Unit: VAR. BUMED  

Parent Organization: BUMED       

Box ID: BX303811

Folder Title: VARIOUS NAVAL MESSAGES FOLDER 1                                                                 

Document Number:          7

Folder SEQ  #:          2








            Immune Globulin (IG) for Hepatitis A is not routinely
        recommended for brief (several days) port visits in urban or
        tourist areas. One can minimize exposure to Hepatitis A by
        avoiding potentially contaminated water or food. Drinking water
        (and beverages with ice) of unknown purity, uncooked or partially
        cooked shellfish, and uncooked fruits or vegetables which are not
        peeled or prepared by the traveler should be avoided.

             immune globulin (gamma globulin) is recommended, however,
        for those whose travel is outside usual tourist routes, those who
        may be unavoidably exposed to food or drinking water in settings
        of questionable sanitation (ex. certain local hosted parties),
        those who will be in contact with local young children in
        settings of poor sanitation, and to those who will be in-country
        for prolonged periods (several weeks). For such travelers, a
        single dose of IG prophylaxis of .02 ml/Kg (approx. two (2) cc
        deep intramuscular injection for the average adult) is recom-
        mended for travel less than three (3) months. For longer periods
        of travel, a different dosage, as well as other unrelated
        preventive medicine concerns, must be addressed and can be
        provided by NEPMU-7.

        6. Malaria

            Low risk. Predominantly vivax malaria is reported to be at a
        low level of endemicity countrywide. There is no risk in urban
        areas. Risk is in rural areas only, except no risk in the
        southern and western districts of Deir-es-zor and Sweida. A
        large outbreak occurred in Dayr-Azzawn and Al Hasakan provinces
        in Jun 82. The primary species is Plasomodiuin vivax with
        occasional P. falciparum. All of the 136 indigenous cases
        detected in 1987 were P. vivax infections originating from the
        foci of Aleppo-Hassan Kabir (86 cases); Lattakia (27); Malkiya,
er (20); Tartous, Hamma and Regga (I
        case each). No drug resistant forms reported. The risk is at
        all altitudes below 600 meters. The risk period is May Thru Oct.

            Chemoprophylaxis with chloroquine and terminal prophylaxis
        with chloroquine/primaquine are recommended for risk areas during
        risk periods. NOTE: Primaquine should not be given to persons
        known to be G6PD defficient. Individuals who do not receive
        primaquine should be counselled that they may experience a
        delayed case of relapsing (vivax or ovale) malaria weeks to years
        after exposure. All febrile episodes should be reported to a
        physician, who should be made aware of the possibility of
        malaria. In general, relapsing malaria is easily treated and not
        life-threatening. Personal Protective measures (such as proper
        clothing, DEET, and bed nets) should always be stressed.

            Medical Department personnel should review the laboratory and
        clinical diagnosis of malaria, as well as treatment. An ade-
        quate supply of treatment drugs such as Fansidar, Quinine,

                                         2

Document 16 f:/Week-37/BX303811/VARIOUS NAVAL MESSAGES FOLDER 1/disease risk assessement profile:1018961449592
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-37
Box ID = BX303811
Unit = VAR. BUMED
Parent Organization = BUMED
Folder Title = VARIOUS NAVAL MESSAGES FOLDER 1
Folder Seq # = 2
Subject = DISEASE RISK ASSESSEMENT PROFILE
Document Seq # = 7
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 18-OCT-1996